Drug Shortage Report for DEPO-MEDROL 80 MG/ML
Report ID | 222049 |
Drug Identification Number | 00030767 |
Brand name | DEPO-MEDROL 80 MG/ML |
Common or Proper name | DEPO-MEDROL 80 MG/ML |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPREDNISOLONE ACETATE |
Strength(s) | 80MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR INTRASYNOVIAL INTRAMUSCULAR INTRALESIONAL INTRA-ARTICULAR |
Packaging size | 5 X 1ML |
ATC code | H02AB |
ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-04-11 |
Actual start date | |
Estimated end date | 2024-05-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2024-04-12 | English | Compare |
v2 | 2024-03-13 | French | Compare |
v1 | 2024-03-13 | English | Compare |
Showing 1 to 3 of 3